Latest Breaking News On - Vertex pain steering committee - Page 1 : comparemela.com

Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral Neuropathy

– Treatment with the NaV1.8 inhibitor VX-548 led to statistically significant and clinically meaningful reduction in the primary endpoint of change from baseline in the Numeric Pain Rating Scale .

City ofUnited kingdomUnited statesStroy freemanCarmen bozicVertex pain steering committeeExchange commissionGlobal medicines developmentBeth israel deaconess medical centerVertex pharmaceuticals incorporated nasdaqCompanies to workVertex pharmaceuticals conference callVertex pharmaceuticals incorporatedNumeric pain rating scaleExecutive vice presidentMedical affairs

Vertex Pharma (VRTX) Reports Positive Results From Phase 2 Study of VX-548

Vertex Pharma (VRTX) Reports Positive Results From Phase 2 Study of VX-548
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Stroy freemanCarmen bozicBeth israel deaconess medical centerGlobal medicines developmentVertex pain steering committeeVertex pharmaceuticals incorporated nasdaqVertex pharmaceuticals incorporatedNumeric pain rating scaleExecutive vice presidentMedical affairsChief medical officerPeripheral nerve disordersPain steeringReference arm

Vertex Pharmaceuticals Incorporated: Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral Neuropathy

Vertex Pharmaceuticals Incorporated: Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral Neuropathy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomStefan klotterHeather nicholsCarmen bozicMiroslava minkovaStroy freemanSusie lisaVertex pharmaceuticals incorporated nasdaqCompanies to workVertex pharmaceuticals conference callVertex pharmaceuticals incorporatedVertex pain steering committeeExchange commissionBeth israel deaconess medical center

Vertex Stock Hits Record High on Phase 2 Study Results and Gene-Editing Deal

Vertex Pharmaceuticals shares hit a record high after the results of a pain medicine study and announcing a gene-editing technology agreement.

Stroy freemanCarmen bozicDrug administrationGlobal medicines developmentVertex pain steering committeeVertex pharmaceuticalsAffairs drPeripheral nerve disordersBeth israel deaconess medical centerPain steering committeeChief medical officerExecutive vice presidentMedical affairsEditas medicineEdita cas